Home › Digestive Diseases › Texas › Tyler
Digestive Diseases clinical trials in Tyler, TX
5 studies for Digestive Diseases are looking for participants at sites in and around Tyler (within about 30 miles). Open a study to see who can join and how to contact the study team.
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RecruitingPhase 3
- Texas Oncology - Northeast Texas, Tyler
Product Surveillance Registry
RecruitingObservational study
- Tyler, Tyler
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
RecruitingPhase 3
- 89bio Clinical Study Site, Tyler
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
RecruitingPhase 3
- 89bio Clinical Study Site, Tyler
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
RecruitingPhase 2
- Tyler Research Institute, Tyler
About Digestive Diseases
Learn about digestive disorders and how your gastrointestinal (GI) system works. Find out what tests you need in case you sense a problem.
More about Digestive Diseases on MedlinePlus
Digestive Diseases trials in other cities
- New York City, NY8 studies
- Chicago, IL8 studies
- Houston, TX8 studies
- Boston, MA6 studies
- Durham, NC6 studies
- Washington, DC6 studies
- San Diego, CA6 studies
- Nashville, TN5 studies
- St. Louis, MO5 studies
- Rochester, MN5 studies
- San Antonio, TX5 studies
- Jacksonville, FL5 studies
Other studies in Tyler
- Non-Small Cell Lung Cancer20 studies
- Crohn's Disease16 studies
- Ulcerative Colitis14 studies
- Heart Failure8 studies
- Colorectal Cancer8 studies
- Ovarian Cancer7 studies
- Cancer (all types)7 studies
- Endometrial Cancer6 studies
- Head and Neck Squamous Cell Carcinoma6 studies
- Breast Cancer6 studies
- Chronic Lymphocytic Leukemia5 studies
- Small Cell Lung Cancer5 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.